Partnership in early drug development
April 10, 2012
More than 400,000 babies are to be screened for debilitating, rare inherited conditions, as part of a pilot which aims to discover if more rare illnesses can be identified and treated early on, the government has announced.
October 12, 2011
Pfizer has linked up with US firm GlycoMimetics to get access to the latter's mid-stage treatment for a complication of sickle cell disease
PharmaTimes 2013 Copyright | RSS Feed Subscriptions Website by DCSL Software